Immune response to mold allergens

The immune response to mold allergens is a complex physiological process where the immune system overreacts to fungal spores or hyphal fragments (Crameri et al., 2014, PubMed). This response is primarily driven by Type I hypersensitivity, involving the production of mold-specific IgE antibodies that sensitize mast cells and basophils (Twaroch et al., 2015, PubMed). Upon subsequent exposure, the release of inflammatory mediators triggers symptoms ranging from allergic rhinitis to severe asthma exacerbations (AAFA, 2024). In some cases, such as Allergic Bronchopulmonary Aspergillosis (ABPA), the response also involves Type III hypersensitivity and chronic airway remodeling (StatPearls, 2023). Therapeutic strategies do not target the "response" as a single entity but rather focus on specific molecular mediators within the pathway, such as IgE or Th2-associated cytokines (IL-4, IL-5, IL-13), to alleviate clinical symptoms and prevent long-term lung damage (Mayo Clinic, 2023).

Other names

Mold allergyFungal hypersensitivityAllergic fungal airway diseaseFungal sensitizationType I hypersensitivity to fungi

Pharmacological intervention typically involves neutralizing IgE, blocking Th2 cytokines (IL-4, IL-5, IL-13), or reducing the fungal burden to dampen the overall immune hypersensitivity.